Related references
Note: Only part of the references are listed.17β-Estradiol Accelerates Tumor Onset and Decreases Survival in a Transgenic Mouse Model of Ovarian Cancer
Laura A. Laviolette et al.
ENDOCRINOLOGY (2010)
Is quantitative oestrogen receptor expression useful in the evaluation of the clinical prognosis? Analysis of a homogeneous series of 797 patients with prospective determination of the ER status using simultaneous EIA and IHC
Chafika Mazouni et al.
EUROPEAN JOURNAL OF CANCER (2010)
Increased Ovarian Cancer Risk Associated With Menopausal Estrogen Therapy Is Reduced by Adding a Progestin
Celeste Leigh Pearce et al.
CANCER (2009)
Nuclear and cytoplasmic expression of ERβ1, ERβ2, and ERβ5 identifies distinct prognostic outcome for breast cancer patients
Abeer M. Shaaban et al.
CLINICAL CANCER RESEARCH (2008)
Estrogen receptor subtypes in ovarian cancer - A clinical correlation
Karen K. L. Chan et al.
OBSTETRICS AND GYNECOLOGY (2008)
Spontaneous neoplasms observed in cynomolgus monkeys (Macaca fascicularis) during a 15-year period
J. Kaspareit et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2007)
Expression of g protein-coupled receptor 30 in the hamster ovary: Differential regulation by Gonadotropins and steroid hormones
Cheng Wang et al.
ENDOCRINOLOGY (2007)
The effects of oestrogen receptors α and β on testicular cell number and steroidogenesis in mice
M. L. Gould et al.
REPRODUCTION (2007)
Menopausal hormone therapy and ovarian cancer risk in the National Institutes of Health-AARP Diet and Health Study Cohort
James V. Lacey et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Estrogen receptor (ER)-β isoforms:: A key to understanding ER-β signaling
Yuet-Kin Leung et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
Estrogen receptor beta, a possible tumor suppressor involved in ovarian carcinogenesis
G Lazennec
CANCER LETTERS (2006)
Menopausal hormones and risk of ovarian cancer
PG Moorman et al.
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY (2005)
Ovarian aging and the perimenopausal transition
JC Prior
ENDOCRINE (2005)
Single-chain estrogen receptors (ERs) reveal that the ERα/β heterodimer emulates functions of the ERα dimer in genomic estrogen signaling pathways
XD Li et al.
MOLECULAR AND CELLULAR BIOLOGY (2004)
Estrogen replacement therapy and ovarian cancer
AR Folsom et al.
EPIDEMIOLOGY (2004)
Estrogen receptor beta inhibits human breast cancer cell proliferation and tumor formation by causing a G(2) cell cycle arrest
S Paruthiyil et al.
CANCER RESEARCH (2004)
Epithelial ovarian cancer risk by invasiveness and cell type in the Central Valley of California
PK Mills et al.
GYNECOLOGIC ONCOLOGY (2004)
Smad 3 regulates proliferation of the mouse ovarian surface epithelium
D Symonds et al.
ANATOMICAL RECORD PART A-DISCOVERIES IN MOLECULAR CELLULAR AND EVOLUTIONARY BIOLOGY (2003)
Spontaneous ovarian tumors in twelve baboons: a review of ovarian neoplasms in non-human primates
CM Moore et al.
JOURNAL OF MEDICAL PRIMATOLOGY (2003)
Estrogen receptor α and β expression in theca and granulosa cells from women with polycystic ovary syndrome
AJ Jakimiuk et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2002)
Menopausal hormone replacement therapy and risk of ovarian cancer
JV Lacey et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2002)
ERβ inhibits proliferation and invasion of breast cancer cells
G Lazennec et al.
ENDOCRINOLOGY (2001)
Ovarian surface epithelium: Biology, endocrinology, and pathology
N Auersperg et al.
ENDOCRINE REVIEWS (2001)
Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women
C Rodriguez et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2001)
Incidence and spectrum of spontaneous neoplasms in male and female CBA/J mice
T Tillmann et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2000)
Share Paper
